Stock UniverseDerived research view · source repositories remain read-only

Medtronic plc (MDT)

Life Science Tools / Diagnostics / MedTech · Healthcare / Medical Devices
Score Band
High
Selection Score
44.01
Global Rank
132
Market Cap
125.38B
Latest Close
81.67
RS Composite
-15.28% · G#2401

Price Movement

3Y daily adjusted close
Loading price data...
Adjusted close SMA60D
1M
5.24%
3M
-9.42%
6M
-18.66%
1Y
-1.56%
3Y
8.78%
5Y
-24.84%
10Y
31.23%

Volume

Loading volume data...
Volume Volume MA20D

Latest volume: 15.28M · 30-day average: 11.46M · Max drawdown over stored range: -45.10%

Research Snapshot

Relative Strength vs SPX

RS Composite-15.28%
20D RS4.12%
60D RS-16.43%
120D RS-23.85%
Global RS Rank2401 · 28.44% percentile
Qualified+ RS Rank911 · 27.58% percentile
Group ScopeQualified+
Primary RS Rank90 · 36.62% percentile
Snapshot Date2026-06-05

RS uses adjusted close where available. Global RS Rank is recalculated from the current non-low pool. Group RS Rank is recalculated inside the company’s own actionable band group.

Research Links

StockAnalysis
Yahoo Finance
Perplexity Finance
Finviz
Seeking Alpha
WhaleWisdom
FinanceCharts
SEC EDGAR Search
SEC Company Search

Official company website and investor-relations URLs are not inferred unless a reliable dynamic source is added.

Classification

Primary Rank8 / 246
Primary Percentile97.15
Score Notesmarket-cap support, industry-tailwind

Gemini Deep Research

Loading Gemini reports...

Manual Estimates

Loading manual estimates...

Forward Valuation

Loading forward valuation...

SEC TTM Fundamentals

PeriodFiledRevenueGross ProfitOperating IncomeNet IncomeEPS DilutedOperating Cash FlowCapital ExpenditureFree Cash FlowShares DilutedGross MarginOperating MarginNet MarginOCF MarginFCF MarginCash + ST Inv.Total Debt
TTM through 2026-01-232026-02-2435.48Bn/a6.03B4.61B3.5810.39B3.35B7.04B1,288Mn/a17.00%13.00%29.27%19.83%8.38B1.76B

SEC TTM. Read-only SEC TTM snapshot. Shares Diluted is the rolling average across the four-quarter window.

TTM Valuation

PeriodEPS DilutedP/ERevenue / ShareP/SFCF / ShareP/FCF MultipleOCF / ShareP/CF Multiple
TTM through 2026-01-23$3.5822.8x$27.553.0x$5.4615.0x$8.0610.1x

Shares Diluted: 1,288M. SEC TTM. Read-only SEC TTM snapshot. Shares Diluted is the rolling average across the four-quarter window.

Financial Statement Metrics

MetricFY 2021FY 2022FY 2023FY 2024FY 2025
Revenue3011731686312273236433537
Revenue Growth (YoY)4.164%5.21%-1.449%3.641%3.624%
Gross Profit1976221658206052127321931
Operating Income54906847556963916403
Free Cash Flow48855978458052005185
Free Cash Flow Per Share3.6084.4243.4363.9094.02
EPS (Diluted) GAAP2.663.732.822.763.61
EPS Growth-24.859%40.226%-24.397%-2.128%30.797%
EPS Non-GAAP
Gross Margin65.617%68.352%65.985%65.73%65.393%
Operating Margin18.229%21.609%17.834%19.747%19.092%
Profit Margin11.973%15.903%12.034%11.358%13.901%
Free Cash Flow Margin16.22%18.866%14.667%16.067%15.461%
Shares Outstanding (Diluted)13541351.41332.81330.21289.9
Shares Change (YoY)0.215%-0.192%-1.376%-0.195%-3.03%

SEC Quarterly Fundamentals

Revenue + Operating Margin
Loading SEC quarterly chart...
Revenue Operating Margin
Quarter Filed Revenue Gross Margin Operating Income Op Margin Net Income Net Margin EPS Diluted Shares Diluted Cash + ST Inv. Total Debt Confidence
2026 Q32026-02-249.02Bn/a1.46B16.24%1.14B12.68%0.891.29B8.38B1.76Bprocessed
2026 Q22025-11-258.96Bn/a1.69B18.81%1.37B15.33%1.071.29B8.33B1.74Bprocessed
2026 Q12025-08-268.58Bn/a1.45B16.85%1.04B12.12%0.811.29B8.12B1.76Bprocessed
2025 Q42025-06-208.93Bn/a1.44B16.09%1.06B11.83%0.821.29B8.96B1.08Bprocessed
2025 Q32025-02-258.29Bn/a1.65B19.85%1.29B15.61%1.011.29B7.92B1.56Bprocessed
2025 Q22024-11-268.40Bn/a1.59B18.98%1.27B15.11%0.991.29B7.99B1.62Bprocessed
2025 Q12024-08-277.92Bn/a1.28B16.15%1.04B13.16%0.801.30B7.84B543.00Mprocessed
2024 Q42024-06-208.59Bn/a1.05B12.26%654.00M7.61%0.491.32B8.01B1.08Bprocessed
2024 Q32024-02-278.09Bn/a1.48B18.33%1.32B16.34%0.991.33B8.32B1.08Bprocessed
2024 Q22023-11-307.98Bn/a1.34B16.78%909.00M11.39%0.681.33B7.73B1.06Bprocessed
2024 Q12023-08-317.70Bn/a1.27B16.46%791.00M10.27%0.591.33B7.88B1.10Bprocessed
2023 Q42023-06-228.54Bn/a1.56B18.31%1.18B13.80%0.881.33B7.96B1.11Bprocessed
2023 Q32023-03-017.73Bn/a1.39B18.01%1.22B15.81%0.921.33B11.14B1.09Bprocessed
2023 Q22022-12-017.58Bn/a1.40B18.51%427.00M5.63%0.321.33B11.43B997.00Mprocessed
2023 Q12022-09-017.37Bn/a1.12B15.26%929.00M12.60%0.701.33B8.87B1.01Bprocessed
2022 Q42022-06-238.09Bn/a1.67B20.66%1.49B18.36%1.101.34B10.57B1.90Bprocessed
2022 Q32022-03-037.76Bn/a1.66B21.37%1.48B19.06%1.101.35B11.22B1.70Bprocessed
2022 Q22021-12-027.85Bn/a1.56B19.92%1.31B16.71%0.971.36B10.67B870.00Mprocessed
2022 Q12021-09-027.99Bn/a859.00M10.75%763.00M9.55%0.561.36B10.60B887.00Mprocessed
2021 Q42021-06-258.19Bn/a1.60B19.60%1.36B16.61%1.001.36B10.82B909.00Mprocessed

SEC processed quarterly CSV. Compact derived quarterly view from SEC processed CSV. Source files remain read-only in the SEC repository. EPS is as filed and may not be split-adjusted across older periods. StockAnalysis Financial Statement Metrics remain unchanged above.